Latest Shareholder Approval News

Wesfarmers has announced a $1.50 per share capital management initiative, combining a $1.10 return of capital with a $0.40 fully-franked special dividend, pending shareholder approval at the upcoming AGM.

Wesfarmers delivered a solid FY25 with revenue rising 3.4% to $45.7 billion and net profit after tax up 14.4%, driven by strong performances in Bunnings and Kmart. The company announced increased dividends and a proposed capital return, while navigating challenges in its lithium business and ongoing cost pressures.

Wesfarmers Limited reported a 14.4% rise in net profit for FY2025, driven by strong retail performances and strategic portfolio moves. The company also announced a fully-franked final dividend and a significant capital management distribution, signaling confidence amid economic headwinds.

Wesfarmers Limited reported a robust 2025 financial year with a 14.4% increase in net profit after tax to $2.926 billion and declared fully franked dividends of $2.06 per share. The conglomerate also unveiled a proposed $1.50 per share capital management distribution, pending shareholder approval.

Platinum Asset Management reports improved FY2025 financials alongside a transformative merger proposal with L1 Capital, aiming to create a $16.5 billion alternative asset manager.

Platinum Asset Management reported a sharp 86% drop in profit for FY25, driven by a 39% decline in funds under management amid sustained outflows and investment challenges. The company announced a transformative merger with L1 Capital, aiming to create a $16.5 billion asset manager.

Imagion Biosystems reported a $1.66 million loss for the half-year ending June 2025 while progressing its MagSense® HER2 Imaging Agent towards a Phase 2 FDA trial and securing $3.5 million in new funding.

Savannah Goldfields Limited has announced a $15 million equity raising through a placement and conditional placement, offering free attaching options subject to shareholder approval. The capital raise aims to strengthen the company’s financial position and support its operational restart plans.

H&G High Conviction Limited reported a $2.9 million net loss for FY2025 amid challenging market conditions and completed a major asset sale to Hancock & Gore Limited, marking a pivotal shift in its business model.

Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.

Savannah Goldfields has announced a $15 million placement to strengthen its balance sheet, repay debt, and fund a restart of gold production alongside an ambitious drilling program targeting resource extensions.

betr Entertainment Limited has increased its takeover offer for PointsBet shares to 4.375 betr shares per PointsBet share, valuing each at $1.40 and surpassing MIXI’s cash bid. The company also expanded its selective buy-back pool to $90 million, signaling confidence in its acquisition strategy.